Guacetisal

DB13538

small molecule experimental

Deskripsi

Struktur Molekul 2D

Berat 286.283
Wujud -

Peta Jejaring Molekuler
Legenda: ObatTargetGenEnzim(Panah → menunjukkan arah efek / relasi)TransporterCarrier

Profil Farmakokinetik

Waktu Paruh (Half-Life) -
Volume Distribusi -
Klirens (Clearance) -

Absorpsi

Data absorpsi tidak tersedia.

Metabolisme

Data metabolisme tidak tersedia.

Rute Eliminasi

Data eliminasi belum tersedia.

Interaksi Obat

1495 Data
Amlodipine Guacetisal may decrease the antihypertensive activities of Amlodipine.
Phentermine The risk or severity of hypertension can be increased when Phentermine is combined with Guacetisal.
Midodrine The risk or severity of hypertension can be increased when Midodrine is combined with Guacetisal.
Eletriptan The risk or severity of hypertension can be increased when Eletriptan is combined with Guacetisal.
Isoetharine The risk or severity of hypertension can be increased when Isoetharine is combined with Guacetisal.
Ziprasidone The risk or severity of hypertension can be increased when Ziprasidone is combined with Guacetisal.
Methysergide The risk or severity of hypertension can be increased when Methysergide is combined with Guacetisal.
Cabergoline The risk or severity of hypertension can be increased when Cabergoline is combined with Guacetisal.
Zolmitriptan The risk or severity of hypertension can be increased when Zolmitriptan is combined with Guacetisal.
Dihydroergotamine The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Guacetisal.
Methylergometrine The risk or severity of hypertension can be increased when Methylergometrine is combined with Guacetisal.
Norepinephrine The risk or severity of hypertension can be increased when Norepinephrine is combined with Guacetisal.
Mirtazapine The risk or severity of hypertension can be increased when Mirtazapine is combined with Guacetisal.
Phenylephrine The risk or severity of hypertension can be increased when Phenylephrine is combined with Guacetisal.
Phenylpropanolamine The risk or severity of hypertension can be increased when Phenylpropanolamine is combined with Guacetisal.
Promazine The risk or severity of hypertension can be increased when Promazine is combined with Guacetisal.
Droperidol The risk or severity of hypertension can be increased when Droperidol is combined with Guacetisal.
Doxapram The risk or severity of hypertension can be increased when Doxapram is combined with Guacetisal.
Atropine The risk or severity of hypertension can be increased when Atropine is combined with Guacetisal.
Lisuride The risk or severity of hypertension can be increased when Lisuride is combined with Guacetisal.
Linezolid The risk or severity of hypertension can be increased when Linezolid is combined with Guacetisal.
Metaraminol The risk or severity of hypertension can be increased when Metaraminol is combined with Guacetisal.
Furazolidone The risk or severity of hypertension can be increased when Furazolidone is combined with Guacetisal.
Epinephrine The risk or severity of hypertension can be increased when Epinephrine is combined with Guacetisal.
Thioridazine The risk or severity of hypertension can be increased when Thioridazine is combined with Guacetisal.
Ergotamine The risk or severity of hypertension can be increased when Ergotamine is combined with Guacetisal.
Nicergoline The risk or severity of hypertension can be increased when Nicergoline is combined with Guacetisal.
Sufentanil The risk or severity of hypertension can be increased when Sufentanil is combined with Guacetisal.
Methoxamine The risk or severity of hypertension can be increased when Methoxamine is combined with Guacetisal.
Risperidone The risk or severity of hypertension can be increased when Risperidone is combined with Guacetisal.
Tranylcypromine The risk or severity of hypertension can be increased when Tranylcypromine is combined with Guacetisal.
Isoflurane The risk or severity of hypertension can be increased when Isoflurane is combined with Guacetisal.
Propiomazine The risk or severity of hypertension can be increased when Propiomazine is combined with Guacetisal.
Alfentanil The risk or severity of hypertension can be increased when Alfentanil is combined with Guacetisal.
Minaprine The risk or severity of hypertension can be increased when Minaprine is combined with Guacetisal.
Orciprenaline The risk or severity of hypertension can be increased when Orciprenaline is combined with Guacetisal.
Propofol The risk or severity of hypertension can be increased when Propofol is combined with Guacetisal.
Phenmetrazine The risk or severity of hypertension can be increased when Phenmetrazine is combined with Guacetisal.
Trifluoperazine The risk or severity of hypertension can be increased when Trifluoperazine is combined with Guacetisal.
Pseudoephedrine The risk or severity of hypertension can be increased when Pseudoephedrine is combined with Guacetisal.
Benzphetamine The risk or severity of hypertension can be increased when Benzphetamine is combined with Guacetisal.
Ritodrine The risk or severity of hypertension can be increased when Ritodrine is combined with Guacetisal.
Flupentixol The risk or severity of hypertension can be increased when Flupentixol is combined with Guacetisal.
Remifentanil The risk or severity of hypertension can be increased when Remifentanil is combined with Guacetisal.
Bitolterol The risk or severity of hypertension can be increased when Bitolterol is combined with Guacetisal.
Oxymetazoline The risk or severity of hypertension can be increased when Oxymetazoline is combined with Guacetisal.
Diethylpropion The risk or severity of hypertension can be increased when Diethylpropion is combined with Guacetisal.
Salmeterol The risk or severity of hypertension can be increased when Salmeterol is combined with Guacetisal.
Naratriptan The risk or severity of hypertension can be increased when Naratriptan is combined with Guacetisal.
Formoterol The risk or severity of hypertension can be increased when Formoterol is combined with Guacetisal.
Frovatriptan The risk or severity of hypertension can be increased when Frovatriptan is combined with Guacetisal.
Methoxyflurane The risk or severity of hypertension can be increased when Methoxyflurane is combined with Guacetisal.
Selegiline The risk or severity of hypertension can be increased when Selegiline is combined with Guacetisal.
Ergoloid mesylate The risk or severity of hypertension can be increased when Ergoloid mesylate is combined with Guacetisal.
Isoprenaline The risk or severity of hypertension can be increased when Isoprenaline is combined with Guacetisal.
Arbutamine The risk or severity of hypertension can be increased when Arbutamine is combined with Guacetisal.
Dutasteride The risk or severity of hypertension can be increased when Dutasteride is combined with Guacetisal.
Halothane The risk or severity of hypertension can be increased when Halothane is combined with Guacetisal.
Moclobemide The risk or severity of hypertension can be increased when Moclobemide is combined with Guacetisal.
Pergolide The risk or severity of hypertension can be increased when Pergolide is combined with Guacetisal.
Desflurane The risk or severity of hypertension can be increased when Desflurane is combined with Guacetisal.
Finasteride The risk or severity of hypertension can be increased when Finasteride is combined with Guacetisal.
Aripiprazole The risk or severity of hypertension can be increased when Aripiprazole is combined with Guacetisal.
Isocarboxazid The risk or severity of hypertension can be increased when Isocarboxazid is combined with Guacetisal.
Ergometrine The risk or severity of hypertension can be increased when Ergometrine is combined with Guacetisal.
Lisdexamfetamine The risk or severity of hypertension can be increased when Lisdexamfetamine is combined with Guacetisal.
Fenoterol The risk or severity of hypertension can be increased when Fenoterol is combined with Guacetisal.
Pirbuterol The risk or severity of hypertension can be increased when Pirbuterol is combined with Guacetisal.
Ephedra sinica root The risk or severity of hypertension can be increased when Ephedra sinica root is combined with Guacetisal.
Ephedrine The risk or severity of hypertension can be increased when Ephedrine is combined with Guacetisal.
Mephentermine The risk or severity of hypertension can be increased when Mephentermine is combined with Guacetisal.
Procaterol The risk or severity of hypertension can be increased when Procaterol is combined with Guacetisal.
Yohimbine The risk or severity of hypertension can be increased when Yohimbine is combined with Guacetisal.
Methotrimeprazine The risk or severity of hypertension can be increased when Methotrimeprazine is combined with Guacetisal.
Clenbuterol The risk or severity of hypertension can be increased when Clenbuterol is combined with Guacetisal.
Bambuterol The risk or severity of hypertension can be increased when Bambuterol is combined with Guacetisal.
MMDA The risk or severity of hypertension can be increased when MMDA is combined with Guacetisal.
Midomafetamine The risk or severity of hypertension can be increased when Midomafetamine is combined with Guacetisal.
2,5-Dimethoxy-4-ethylamphetamine The risk or severity of hypertension can be increased when 2,5-Dimethoxy-4-ethylamphetamine is combined with Guacetisal.
4-Methoxyamphetamine The risk or severity of hypertension can be increased when 4-Methoxyamphetamine is combined with Guacetisal.
4-Bromo-2,5-dimethoxyamphetamine The risk or severity of hypertension can be increased when 4-Bromo-2,5-dimethoxyamphetamine is combined with Guacetisal.
Tenamfetamine The risk or severity of hypertension can be increased when Tenamfetamine is combined with Guacetisal.
Chlorphentermine The risk or severity of hypertension can be increased when Chlorphentermine is combined with Guacetisal.
Dextroamphetamine The risk or severity of hypertension can be increased when Dextroamphetamine is combined with Guacetisal.
Phendimetrazine The risk or severity of hypertension can be increased when Phendimetrazine is combined with Guacetisal.
Solifenacin The risk or severity of hypertension can be increased when Solifenacin is combined with Guacetisal.
Periciazine The risk or severity of hypertension can be increased when Periciazine is combined with Guacetisal.
Acepromazine The risk or severity of hypertension can be increased when Acepromazine is combined with Guacetisal.
Thioproperazine The risk or severity of hypertension can be increased when Thioproperazine is combined with Guacetisal.
Zuclopenthixol The risk or severity of hypertension can be increased when Zuclopenthixol is combined with Guacetisal.
Epicaptopril The risk or severity of hypertension can be increased when Epicaptopril is combined with Guacetisal.
Clorgiline The risk or severity of hypertension can be increased when Clorgiline is combined with Guacetisal.
1-benzylimidazole The risk or severity of hypertension can be increased when 1-benzylimidazole is combined with Guacetisal.
Iproniazid The risk or severity of hypertension can be increased when Iproniazid is combined with Guacetisal.
Nialamide The risk or severity of hypertension can be increased when Nialamide is combined with Guacetisal.
Lysergic acid diethylamide The risk or severity of hypertension can be increased when Lysergic acid diethylamide is combined with Guacetisal.
Dronedarone The risk or severity of hypertension can be increased when Dronedarone is combined with Guacetisal.
Flibanserin The risk or severity of hypertension can be increased when Flibanserin is combined with Guacetisal.
Iloperidone The risk or severity of hypertension can be increased when Iloperidone is combined with Guacetisal.
Indacaterol The risk or severity of hypertension can be increased when Indacaterol is combined with Guacetisal.

Referensi & Sumber

Belum ada data referensi/link/attachment untuk obat ini pada database. Jalankan import DrugBank untuk mengisi field referensi.

Contoh Produk & Brand

Produk: 0 • International brands: 0
Belum ada data produk/brand untuk obat ini pada database. Jalankan import DrugBank untuk mengisi field produk/brand.

Sekuens Gen/Protein (FASTA)

Sekuens dimuat saat dibutuhkan agar halaman tetap ringan.
© 2025 Digital Pharmacy Research - Universitas Esa Unggul